Ravi Iyengar, PhD
Icahn School of Medicine at Mount Sinai
Core:
Systems, Modeling and Computation
Dr. Iyengar's expertise is in the systems biology of cellular regulatory networks. He uses a combination of experimental and computational approaches to study how systems-level regulation of molecular interactions propagate across scales of organization to produce organ-level physiology and pathophysiology. His group is developing large- scale network models of drug-target interactions within the human interactome and using these systems to develop classifiers that are used to explain adverse events in the FDA adverse event database. He is the Dorothy H and Lewis Rosenstiel Professor in the Department of Pharmacology and Systems Therapeutics and Director of the Systems Biology Center New York at the Icahn School of Medicine at Mount Sinai.
Publications: